UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053042
Receipt number R000060516
Scientific Title Research on the effectiveness of welfare nails on the quality of life of cancer patients
Date of disclosure of the study information 2024/01/01
Last modified on 2023/12/09 11:11:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on the effectiveness of welfare nails on the quality of life of cancer patients

Acronym

welfare nails for cancer patients

Scientific Title

Research on the effectiveness of welfare nails on the quality of life of cancer patients

Scientific Title:Acronym

RENAIL trial

Region

Japan


Condition

Condition

all kinds of malignant tumor

Classification by specialty

Medicine in general Gastroenterology Hepato-biliary-pancreatic medicine
Pneumology Hematology and clinical oncology Psychosomatic Internal Medicine
Surgery in general Gastrointestinal surgery Hepato-biliary-pancreatic surgery
Chest surgery Breast surgery Dermatology
Psychiatry Oto-rhino-laryngology Urology
Neurosurgery Plastic surgery Aesthetic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Cancer treatment often results in changes in appearance, such as skin disorders, hair loss and deformed or discoloured nails, due to surgery, drugs and radiotherapy. Changes in appearance associated with cancer treatment, such as hair loss, skin disorders and scarring, were long considered unavoidable in exchange for life, despite being high on the list of patient distress. However, in the modern era of extended patient survival and a marked increase in the number of working patients, appearance-related appearance care has been positioned as a major pillar of supportive care by healthcare professionals for the purpose of continuing and promoting cancer treatment. In fact, the issue of 'appearance' was taken up for the first time in the Third Basic Plan for the Promotion of Cancer Control and Prevention in 2018, which calls for the construction of a society where people can live with dignity and peace of mind, and requires healthcare professionals to provide appropriate support for appearance issues in order to improve patients' quality of life. This study focuses particularly on nail deformity and aims to analyse the psychological impact of welfare nail intervention as appearance care on cancer patients attending the Kumamoto University Hospital Outpatient Chemotherapy Centre in terms of patient QOL, depression and anxiety, and to examine its effectiveness.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Improvements in quality of life measures (DLQI) before and after intervention

Key secondary outcomes

Improvements in quality of life scales (EORTC-QLQ-C30, FACT-G) before and after intervention
Improvement in the Depression and Anxiety Scale (HADS) pre- and post-intervention
Improvement in Nail Disorder Severity Index (NADSI)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver Other

Interventions/Control_1

A welfare nail intervention every two weeks for three months, followed by a questionnaire survey and interviews about the psychological impact of the intervention, including quality of life, depression and anxiety. The care nail intervention is not a medical treatment and is considered non-invasive. The psychological investigation falls under the case where sufficient care is taken in the questionnaire-based question survey, such as clearly indicating in advance that it includes contents that may cause psychological distress to the research subjects, and the research subjects can respond or refuse to respond anonymously, and is judged to be slightly invasive overall as this study.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Cancer patients attending the Outpatient Chemotherapy Centre of Kumamoto University Hospital who agree to the welfare nail intervention will be included in the study. As a control grouppatients who do not agree to the welfare nail intervention but agree to the questionnaire-based study will also be included in the study.

Key exclusion criteria

Patients who require dermatological treatment for nails, e.g. due to infection, are excluded.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name SATOSHI
Middle name
Last name FUKUSHIMA

Organization

KUMAMOTO UNIVERSITY HOSPITAL

Division name

Dermatology

Zip code

860-8556

Address

1-1-1, Honjo, Chuo-ku, Kumamoto

TEL

096-373-5233

Email

s_fukushima@kumamoto-u.ac.jp


Public contact

Name of contact person

1st name SATOSHI
Middle name
Last name FUKUSHIMA

Organization

KUMAMOTO UNIVERSITY HOSPITAL

Division name

Dermatology

Zip code

860-8556

Address

1-1-1, Honjo, Chuo-ku, Kumamoto

TEL

096-373-5233

Homepage URL


Email

s_fukushima@kumamoto-u.ac.jp


Sponsor or person

Institute

Kumamoto University

Institute

Department

Personal name



Funding Source

Organization

Kumamoto University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB

Address

1-1-1, Honjo, Chuo-ku, Kumamoto

Tel

096-373-5657

Email

byi-senshin@jimu.kumamoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

熊本大学病院


Other administrative information

Date of disclosure of the study information

2024 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 12 Month 09 Day

Date of IRB


Anticipated trial start date

2024 Year 04 Month 01 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 12 Month 09 Day

Last modified on

2023 Year 12 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060516


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name